Therefore, our data are not incompatible with a role of SMARCA4 as a tumor suppressor when it is mutated in certain types of tumors, probably due to the pathological activity of aberrant residual SWI/SNF complexes. The gene discussed is SMARCA1; the disease is neoplasm.